Osivax receives $19.5 million BARDA support for universal flu vaccine candidate
iLexx / iStock CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) announced today that it is awarding $1.1 million to biotechnology company ...